SCHEMBL6169823

SCHEMBL6169823

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)CCCCc2ccc(F)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
MAPT P10636 8/20 0.47
ALDH1A1 P00352 4/20 0.47
PKM P14618 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
LMNA P02545 2/20 0.46
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.46
PTGER4 P35408 1/20 0.45
MEN1 O00255 3/20 0.44
CETP P11597 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CASP3 P42574 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172673 0.90 KMT2A (0.52) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6169035 0.90 RAB9A (0.59) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6169822 0.90 KMT2A (0.48) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6172642 0.86 RAB9A (0.56) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6172423 0.85 KMT2A (0.48) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6168620 0.85 KMT2A (0.57) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6170345 0.85 KMT2A (0.59) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6169121 0.84 L3MBTL1 (0.48) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6169173 0.83 MAPT (0.65) KMT2ARAB9ANPC1MAPTALDH1A1
SCHEMBL6170745 0.83 KMT2A (0.50) KMT2ARAB9ANPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed